← brief for 2026-10-11 · Slowing decline
Biomarkers and Risk Prediction in Cardiovascular-Kidney-Metabolic Syndrome: A Comprehensive Review.
Key takeaways
This review discusses blood tests that can predict how heart and kidney diseases will progress. It covers both old and new markers. It is a summary of existing knowledge, not a new trial with fresh results.
Who did this work
Lu Y · Yang M · Yu J · Lin P · Ji J · Ding X · Wang Y · Xu X
Source
Paper · PubMed, CKD progression and prevention · 2026 Sep 16
https://pubmed.ncbi.nlm.nih.gov/42859519/